Andrew J. Cittadine
Equibles does not estimate personal net worth.
Get an email with a short summary when Monopar Therapeutics publishes a filing, an earnings call transcript or a press release.
Get MNPR alertsAbout Andrew J. Cittadine
Andrew J. Cittadine is recorded as COO at Monopar Therapeutics (MNPR). The newest filing on record that lists Andrew J. Cittadine as COO at Monopar Therapeutics (MNPR) is dated April 30, 2026. The proxy statement of Monopar Therapeutics reports total compensation of $4,706,431 for Andrew J. Cittadine in fiscal 2025, including a base salary of $440,000. Disclosed compensation is on record for 4 fiscal years. Monopar Therapeutics is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Monopar Therapeutics includes Chandler D. Robinson (CEO and Board Member), Karthik Radhakrishnan (CFO and Chief Accounting Officer), Quan A. Vu (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Monopar Therapeutics
- Chandler D. Robinson CEO, Board Member
- Karthik Radhakrishnan CFO, Chief Accounting Officer
- Quan A. Vu CFO
- Quan Vu CFO, Chief Accounting Officer
- Andrew Cittadine COO
- Andrew P. Mazar, Ph.D. Board Member
- Arthur J. Klausner, MBA Board Member
- Chandler D. Robinson, MD MBA MSc Board Member
- Christopher M. Starr Board Member
- Christopher M. Starr, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $440,000 | $4,706,431 |
| 2024 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $384,800 | $554,796 |
| 2023 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $360,000 | $911,161 |
| 2022 | Monopar Therapeutics (MNPR) | Chief Operating Officer | $325,000 | $752,326 |
Recent activity
No call appearances or filed executive changes recorded yet.